Key result
CABG improves survival for ~800,000 patients annually worldwide despite offsetting perioperative mortality risks.
CABG benefits remain offset by perioperative mortality; leaves open optimal technique selection in contemporary practice.
Inspired in 1931 by a bedside vigil for a dying patient with massive pulmonary embolism, John Gibbon had by the early 1950s developed the heart–lung machine, or pump oxygenator. Although it affected the management of pulmonary embolism only trivially, the pump made possible the era of modern heart surgery for congenital, valvular, and coronary artery disease. An estimated 800,000 patients per year worldwide undergo coronary-artery bypass grafting in order to achieve the extensively documented improvement in survival and quality of life that it can provide to appropriate candidates.That benefit is offset by a perioperative mortality rate of 1 to . . .
No takes yet. Share an insight, caveat, or question.
Eric A. Rose (2003) conducted an editorial in coronary artery disease. Off-Pump Coronary-Artery Bypass Surgery was evaluated. Coronary-artery bypass grafting is performed in an estimated 800,000 patients per year worldwide to improve survival and quality of life, though benefits are offset by perioperative mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: